publicações selecionadas
-
artigo académico
- RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors. Current Cancer Drug Targets. 2023
- Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. BMC Cancer. 2021
- Matteucinol, isolated from Miconia chamissois, induces apoptosis in human glioblastoma lines via the intrinsic pathway and inhibits angiogenesis and tumor growth in vivo. Investigational New Drugs. 2019
- ID7 Isolated from Bauhinia variegata Stem Inhibits Tumor Progression and Metastatic Mechanisms of Triple Negative Breast Cancer in Vivo. Journal of Pharmacy and Pharmacology. 2019
-
artigo de revista
- In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines.. Experimental and Therapeutic Medicine. 2018
- Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib.. Urologic Oncology-Seminars and Original Investigations. 2017
- Tapirira guianensis Aubl. Extracts inhibits proliferation and migration of oral cancer cells lines. International Journal of Molecular Sciences. 2016
- Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Cellular Oncology. 2016
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas. Translational Oncology. 2013
-
documento